It is not FDA-approved and is not available by prescription in Hollywood, Miami, West Palm Beach, or anywhere in Florida outside of approved clinical trials
Key Takeaways Clinical trials suggest that retatrutide could result in more weight loss and better metabolic health than Ozempic
The Biden administration proposed in November to change Medicares coverage policy for obesity drugs, but currently, Medicare beneficiaries can get coverage for weight-loss medicines only when theyre used for another indication, like reducing heart risks
The region has a highly developed healthcare infrastructure and availability of advanced treatment options
The trial randomised 2,339 adults with obesity (or overweight with a weight-related comorbidity) and without type 2 diabetes to retatrutide 4mg, 9mg, or 12mg weekly (titrated upward from 2mg in four-weekly steps) or placebo
The immunomodulatory effects documented in research are systemic anti-inflammatory effects, not targeted autoimmune therapy